HIV AIDS

Rodger MacArthur, MD, was in his HIV clinic last week and queried his COVID-19 vaccine-hesitant/resistant patients about their reasons. The refrain was familiar and discouraging.

Vaccines from both companies were significantly effective against COVID-19 and show promise against variants from the UK and South Africa.

Cabotegravir and rilpivirine, injectable formulation is administered once-weekly, reducing treatment days for adults with HIV from 365 to 12.

The FDA announced October 3 approval of Descovy®, making it the second drug to receive indication for HIV pre-exposure prophylaxis.

The underpinnings of the global HIV and STI epidemics are inextricable. A new report looks at combined solutions. We offer highlights.

Highlights: The first liquid solution of colchicine for prophylaxis of gout, the first generic version of Advair Diskus, and 8 more new and approved drugs.

A first-of-its-kind study found that among cirrhosis patients with and without HIV-coinfection, liver function improved >50% in each cohort.

What are the top 5 HIV/AIDS apps that both physicians and patients can use? Scroll through our new slideshow to find out. 

Further hope for prevention of transmission as the search for a cure continues.

Research supports liver and kidney transplantation in patients with HIV infection, but referral rates are low.